George Rodrigues
George Rodrigues
Verified email at
Cited by
Cited by
Interpreting the significance of changes in health-related quality-of-life scores
D Osoba, G Rodrigues, J Myles, B Zee, J Pater
Journal of clinical oncology 16 (1), 139-144, 1998
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
DA Palma, R Olson, S Harrow, S Gaede, AV Louie, C Haasbeek, L Mulroy, ...
The Lancet 393 (10185), 2051-2058, 2019
Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part I: risk stratification, shared decision making, and care options
MG Sanda, JA Cadeddu, E Kirkby, RC Chen, T Crispino, J Fontanarosa, ...
The Journal of urology 199 (3), 683-690, 2018
Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial
DA Palma, R Olson, S Harrow, S Gaede, AV Louie, C Haasbeek, L Mulroy, ...
Journal of Clinical Oncology 38 (25), 2830, 2020
Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis
DA Palma, S Senan, K Tsujino, RB Barriger, R Rengan, M Moreno, ...
International Journal of Radiation Oncology* Biology* Physics 85 (2), 444-450, 2013
Height Above the Nearest Drainage–a hydrologically relevant new terrain model
AD Nobre, LA Cuartas, M Hodnett, CD Rennó, G Rodrigues, A Silveira, ...
Journal of Hydrology 404 (1-2), 13-29, 2011
Prediction of radiation pneumonitis by dose–volume histogram parameters in lung cancer—a systematic review
G Rodrigues, M Lock, D D'Souza, E Yu, J Van Dyk
Radiotherapy and oncology 71 (2), 127-138, 2004
An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non–small-cell lung cancer
AB Ashworth, S Senan, DA Palma, M Riquet, YC Ahn, U Ricardi, ...
Clinical lung cancer 15 (5), 346-355, 2014
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised …
DH Brand, AC Tree, P Ostler, H van der Voet, A Loblaw, W Chu, D Ford, ...
The Lancet Oncology 20 (11), 1531-1543, 2019
Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline
GMM Videtic, J Donington, M Giuliani, J Heinzerling, TZ Karas, CR Kelsey, ...
Practical radiation oncology 7 (5), 295-301, 2017
Stage I–II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a …
NE Verstegen, JWA Oosterhuis, DA Palma, G Rodrigues, FJ Lagerwaard, ...
Annals of oncology 24 (6), 1543-1548, 2013
Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature
A Ashworth, G Rodrigues, G Boldt, D Palma
Lung cancer 82 (2), 197-203, 2013
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement
M Guckenberger, C Belka, A Bezjak, J Bradley, ME Daly, D DeRuysscher, ...
Radiotherapy and Oncology 146, 223-229, 2020
Prostate volume contouring: a 3D analysis of segmentation using 3DTRUS, CT, and MR
WL Smith, C Lewis, G Bauman, G Rodrigues, D D’Souza, R Ash, D Ho, ...
International Journal of Radiation Oncology* Biology* Physics 67 (4), 1238-1247, 2007
Radiographic changes after lung stereotactic ablative radiotherapy (SABR)–can we distinguish recurrence from fibrosis? A systematic review of the literature
K Huang, M Dahele, S Senan, M Guckenberger, GB Rodrigues, A Ward, ...
Radiotherapy and Oncology 102 (3), 335-342, 2012
Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review
D Palma, F Lagerwaard, G Rodrigues, C Haasbeek, S Senan
International Journal of Radiation Oncology* Biology* Physics 82 (3), 1149-1156, 2012
Palliative thoracic radiotherapy in lung cancer: An American Society for Radiation Oncology evidence-based clinical practice guideline
G Rodrigues, GMM Videtic, R Sur, A Bezjak, J Bradley, CA Hahn, ...
Practical radiation oncology 1 (2), 60-71, 2011
Pre-treatment risk stratification of prostate cancer patients: A critical review
G Rodrigues, P Warde, T Pickles, J Crook, M Brundage, L Souhami, ...
Canadian Urological Association Journal 6 (2), 121, 2012
Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors
GHMJ Griffioen, D Toguri, M Dahele, A Warner, PF de Haan, ...
Lung cancer 82 (1), 95-102, 2013
Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial
DA Palma, R Olson, S Harrow, RJM Correa, F Schneiders, CJA Haasbeek, ...
BMC cancer 19 (1), 1-15, 2019
The system can't perform the operation now. Try again later.
Articles 1–20